2,316 results on '"Paller, Amy S."'
Search Results
2. Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies
3. Correction to: Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
4. Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
5. Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
6. Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
7. Development of the PROMIS pediatric stigma and extension to the PROMIS pediatric stigma: skin item banks
8. Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study.
9. Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey
10. Juvenile Localized and Systemic Scleroderma
11. Attentiveness and mental health in adolescents with moderate-to-severe atopic dermatitis without ADHD
12. Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis
13. The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases
14. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis
15. Ichthyosis
16. Inpatient management of epidermolysis bullosa: Consensus-based hands-on instructions for neonates and postneonates
17. Preclinical Atopic Dermatitis Skin in Infants: An Emerging Research Area
18. The circadian metabolome of atopic dermatitis
19. Pachyonychia Congenita: A Research Agenda Leading to New Therapeutic Approaches
20. Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors
21. Multiethnic genome-wide and HLA association study of total serum IgE level
22. Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey)
23. A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
24. Secukinumab responses vary across the spectrum of congenital ichthyosis in adults
25. Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies
26. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies
27. Berdazimer gel for molluscum contagiosum: An integrated analysis of 3 randomized controlled trials
28. Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum
29. Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
30. Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
31. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases
32. Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus
33. Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database
34. Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents
35. Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review
36. Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) Registry
37. Guidelines of care for the management of atopic dermatitis in adults with topical therapies
38. Foreword
39. International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale.
40. Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild‐to‐moderate atopic dermatitis
41. Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations
42. Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis
43. Skin-interfaced biosensors for advanced wireless physiological monitoring in neonatal and pediatric intensive-care units
44. Replicated methylation changes associated with eczema herpeticum and allergic response
45. Topical Ozone Accelerates Diabetic Wound Healing by Promoting Re-Epithelialization through the Activation of IGF1R–EGFR Signaling
46. Ichthyosis: presentation and management
47. Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa
48. Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients
49. A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa
50. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.